Roche Pharma India has launched a subcutaneous Tecentriq injection for eligible lung cancer patients. The shorter dosing time could ease hospital visits, though the price remains a key concern.
What if the trick to getting cancer immunotherapy to parts of the world that can’t access it is simply lowering the dose? A ...
Observational Study of Best Supportive Care With or Without Oral Capecitabine in Patients With Metastatic Gallbladder Carcinoma at a Tertiary Center in India The median age at diagnosis was 45.5 years ...
As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally ...
Astellas Pharma India today announced that PADCEV™ (enfortumab vedotin) in combination with pembrolizumab is now approved for the first-line treatment of adult patients with unresectable or metastatic ...
As we close the year 2025, it's clear that oncology is being reshaped by innovation. The pace of progress- from novel drugs and cellular therapies to technological integration and patient-centric care ...
Barriers to Breast Cancer Care for Women Presenting at District and Regional-Level Hospitals in Ghana: Findings From the African Breast Cancer-Disparities in Outcomes Ghana Study Breast cancer remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results